Pertussis Vaccine Performance in an Epidemic Year--Oregon, 2012 | Zendy

Juventila Liko | Zendy; Steve G. Robison | Zendy; Paul R. Cieslak | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pertussis Vaccine Performance in an Epidemic Year--Oregon, 2012

Author(s) -

Juventila Liko,

Steve G. Robison,

Paul R. Cieslak

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu273

Subject(s) - medicine , confidence interval , pertussis vaccine , incidence (geometry) , pediatrics , whooping cough , demography , bordetella pertussis , vaccination , immunology , immunization , antibody , physics , genetics , sociology , biology , bacteria , optics

A 2012 pertussis epidemic in Oregon afforded an opportunity to measure vaccine effectiveness; it ranged from 95% (95% confidence interval [CI], 92%-97%) among children 15-47 months of age to 47% (95% CI, 19%-65%) among adolescents 13-16 years of age. In all age groups, pertussis incidence was higher among unimmunized persons.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research